Evista

In the US, Evista (raloxifene systemic) is a member of the following drug classes: hormones/antineoplastics, selective estrogen receptor modulators and is used to treat Breast Cancer - Prevention, Osteoporosis and Prevention of Osteoporosis.

US matches:

• Evista

UK matches:

• Evista 60mg film-coated tablets

Ingredient matches for Evista

Raloxifene

Raloxifene is reported as an ingredient of Evista in the following countries:

• Tunisia

Raloxifene hydrochloride (a derivative of Raloxifene) is reported as an ingredient of Evista in the following countries:

• Argentina


• Australia


• Austria


• Bahrain


• Belgium


• Bulgaria


• Canada


• Chile


• Colombia


• Costa Rica


• Croatia (Hrvatska)


• Czech Republic


• Denmark


• Dominican Republic


• El Salvador


• Finland


• France


• Germany


• Greece


• Guatemala


• Honduras


• Hong Kong


• Hungary


• Iceland


• Indonesia


• Ireland


• Israel


• Italy


• Japan


• Luxembourg


• Malaysia


• Mexico


• Netherlands


• New Zealand


• Nicaragua


• Norway


• Oman


• Panama


• Peru


• Philippines


• Portugal


• Romania


• Serbia


• Singapore


• Slovakia


• Slovenia


• South Africa


• Spain


• Sri Lanka


• Sweden


• Switzerland


• Taiwan


• Turkey


• United Kingdom


• United States

International Drug Name Search